back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-11-18 15:07 Tx date 2023-11-15 |
$ATE
Antibe Therapeutics Inc. |
Stegic, Ana
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,733
+1,667 vol $1.04 each |
41,700 | |
| Filed 2023-11-18 15:07 Tx date 2023-11-15 |
$ATE
Antibe Therapeutics Inc. |
Stegic, Ana
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-1,733.68
-1,667 vol $1.04 each |
10,000 | |
| Filed 2023-09-15 18:08 Tx date 2023-09-12 |
$ATE
Antibe Therapeutics Inc. |
Stegic, Ana
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+36,000 vol |
48,000 | |
| Filed 2023-05-03 13:27 Tx date 2023-05-01 |
$ATE
Antibe Therapeutics Inc. |
Stegic, Ana
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,799
+3,333 vol $0.54 each |
40,033 | |
| Filed 2023-05-03 13:27 Tx date 2023-05-01 |
$ATE
Antibe Therapeutics Inc. |
Stegic, Ana
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-1,799.82
-3,333 vol $0.54 each |
11,667 | |
| Filed 2022-11-19 12:29 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Stegic, Ana
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$800.16
+1,667 vol $0.48 each |
36,700 | |
| Filed 2022-11-19 12:28 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Stegic, Ana
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-800.16
-1,667 vol $0.48 each |
15,000 | |
| Filed 2022-11-19 12:24 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Stegic, Ana
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,000 vol |
12,000 | |
| Filed 2022-11-19 12:23 Tx date 2021-11-01 |
$ATE
Antibe Therapeutics Inc. |
Stegic, Ana
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-10 19:27 Tx date 2022-05-06 |
$ATE
Antibe Therapeutics Inc. |
Stegic, Ana
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,950
+28,500 vol $0.70 each |
35,033 | |
| Filed 2022-05-05 12:00 Tx date 2022-05-02 |
$ATE
Antibe Therapeutics Inc. |
Stegic, Ana
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,333 vol |
6,533 | |
| Filed 2022-05-05 11:59 Tx date 2022-05-02 |
$ATE
Antibe Therapeutics Inc. |
Stegic, Ana
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,333 vol |
16,667 | |
| Filed 2021-11-19 20:54 Tx date 2021-11-15 |
$ATE
Antibe Therapeutics Inc. |
Stegic, Ana
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+10,000 vol |
20,000 | |
| Filed 2021-11-02 15:50 Tx date 2021-11-01 |
$ATE
Antibe Therapeutics Inc. |
Stegic, Ana
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,403
+2,700 vol $0.89 each |
3,200 | |
| Filed 2021-11-02 15:42 Tx date 2021-11-01 |
$ATE
Antibe Therapeutics Inc. |
Stegic, Ana
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$435.00
+500 vol $0.87 each |
500 | |
| Filed 2021-11-02 15:37 Tx date 2021-11-01 |
$ATE
Antibe Therapeutics Inc. |
Stegic, Ana
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-02 15:36 Tx date 2021-11-01 |
$ATE
Antibe Therapeutics Inc. |
Stegic, Ana
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
10,000 |